|
1
|
Kumar V; Abass KA, Fausto N and Mitchell
R: Robbins Basic Pathology. 8th edition. Saunders Elsevier;
Philadelphia, PA: 2007
|
|
2
|
Brambilla E, Travis WD, Colby TV, Corrin B
and Shimosato Y: The new World Health Organization classification
of lung tumours. Eur Respir J. 18:1059–1068. 2001. View Article : Google Scholar
|
|
3
|
Chu XY, Hou XB, Song WA, Xue ZQ, Wang B
and Zhang LB: Diagnostic values of SCC, CEA, Cyfra21-1 and NSE for
lung cancer in patients with suspicious pulmonary masses: A single
center analysis. Cancer Biol Ther. 11:995–1000. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Portela A and Esteller M: Epigenetic
modifications and human disease. Nat Biotechnol. 28:1057–1068.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Takai D and Jones PA: Comprehensive
analysis of CpG islands in human chromosomes 21 and 22. Proc Natl
Acad Sci USA. 99:3740–3745. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Grønbaek K, Hother C and Jones PA:
Epigenetic changes in cancer. APMIS. 115:1039–1059. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lokk K, Vooder T, Kolde R, Välk K, Võsa U,
Roosipuu R, Milani L, Fischer K, Koltsina M, Urgard E, et al:
Methylation markers of early-stage non-small cell lung cancer. PLoS
One. 7:e398132012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tekpli X, Landvik NE, Anmarkud KH, Skaug
V, Haugen A and Zienolddiny S: DNA methylation at promoter regions
of interleukin 1B, interleukin 6, and interleukin 8 in non-small
cell lung cancer. Cancer Immunol Immunother. 62:337–345. 2013.
View Article : Google Scholar
|
|
9
|
Sato T, Arai E, Kohno T, Tsuta K, Watanabe
S, Soejima K, Betsuyaku T and Kanai Y: DNA methylation profiles at
precancerous stages associated with recurrence of lung
adenocarcinoma. PLoS One. 8:e594442013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pesta M, Kulda V, Topolcan O, Safranek J,
Vrzalova J, Cerny R and Holubec L: Significance of methylation
status and the expression of RECK mRNA in lung tissue of patients
with NSCLC. Anticancer Res. 29:4535–4539. 2009.PubMed/NCBI
|
|
11
|
Suzuki M, Shiraishi K, Eguchi A, Ikeda K,
Mori T, Yoshimoto K, Ohba Y, Yamada T, Ito T, Baba Y, et al:
Aberrant methylation of LINE-1, SLIT2, MAL and IGFBP7 in non-small
cell lung cancer. Oncol Rep. 29:1308–1314. 2013.PubMed/NCBI
|
|
12
|
Grimminger PP, Maus MK, Schneider PM,
Metzger R, Hölscher AH, Sugita H, Danenberg PV, Alakus H and
Brabender J: Glutathione S-transferase PI (GST-PI) mRNA expression
and DNA methylation is involved in the pathogenesis and prognosis
of NSCLC. Lung Cancer. 78:87–91. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Duan H, He Z, Ma J, Zhang B, Sheng Z, Bin
P, Cheng J, Niu Y, Dong H, Lin H, et al: Global and MGMT promoter
hypomethylation independently associated with genomic instability
of lymphocytes in subjects exposed to high-dose polycyclic aromatic
hydrocarbon. Arch Toxicol. 87:2013–2022. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tadjuidje E and Hegde RS: The eyes absent
proteins in development and disease. Cell Mol Life Sci.
70:1897–1913. 2013. View Article : Google Scholar :
|
|
15
|
Huang YT, Heist RS, Chirieac LR, Lin X,
Skaug V, Zienolddiny S, Haugen A, Wu MC, Wang Z, Su L, et al:
Genome-wide analysis of survival in early-stage non-small-cell lung
cancer. J Clin Oncol. 27:2660–2667. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bierkens M, Krijgsman O, Wilting SM, Bosch
L, Jaspers A, Meijer GA, Meijer CJ, Snijders PJ, Ylstra B and
Steenbergen RD: Focal aberrations indicate EYA2 and hsa-miR-375 as
oncogene and tumor suppressor in cervical carcinogenesis. Genes
Chromosomes Cancer. 52:56–68. 2013. View Article : Google Scholar
|
|
17
|
Farabaugh SM, Micalizzi DS, Jedlicka P,
Zhao R and Ford HL: Eya2 is required to mediate the pro-metastatic
functions of Six1 via the induction of TGF-β signaling,
epithelial-mesenchymal transition, and cancer stem cell properties.
Oncogene. 31:552–562. 2012.
|
|
18
|
Zhang L, Yang N, Huang J, Buckanovich RJ,
Liang S, Barchetti A, Vezzani C, O'Brien-Jenkins A, Wang J, Ward
MR, et al: Transcriptional coactivator Drosophila eyes absent
homologue 2 is up-regulated in epithelial ovarian cancer and
promotes tumor growth. Cancer Res. 65:925–932. 2005.PubMed/NCBI
|
|
19
|
Yeh PA, Yang WH, Chiang PY, Wang SC, Chang
MS and Chang CJ: Drosophila eyes absent is a novel mRNA target of
the tristetraprolin (TTP) protein DTIS11. Int J Biol Sci.
8:606–619. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zou H, Harrington JJ, Shire AM, Rego RL,
Wang L, Campbell ME, Oberg AL and Ahlquist DA: Highly methylated
genes in colorectal neoplasia: implications for screening. Cancer
Epidemiol, Biomarkers Prev. 16:2686–2696. 2007. View Article : Google Scholar
|
|
21
|
Vincent A, Hong SM, Hu C, Omura N, Young
A, Kim H, Yu J, Knight S, Ayars M, Griffith M, et al: Epigenetic
silencing of EYA2 in pancreatic adenocarcinomas promotes tumor
growth. Oncotarget. 5:2575–2587. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jemc J and Rebay I: Identification of
transcriptional targets of the dual-function transcription
factor/phosphatase eyes absent. Dev Biol. 310:416–429. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jemc J and Rebay I: The eyes absent family
of phosphotyrosine phosphatases: Properties and roles in
developmental regulation of transcription. Annu Rev Biochem.
76:513–538. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Krishnan N, Jeong DG, Jung SK, Ryu SE,
Xiao A, Allis CD, Kim SJ and Tonks NK: Dephosphorylation of the
C-terminal tyrosyl residue of the DNA damage-related histone H2A.X
is mediated by the protein phosphatase eyes absent. J Biol Chem.
284:16066–16070. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Spackman E and Suarez DL: Type A influenza
virus detection and quantitation by real-time RT-PCR. Methods Mol
Biol. 436:19–26. 2008.PubMed/NCBI
|
|
26
|
Kobayashi H and Kono T: DNA methylation
analysis of germ cells by using bisulfite-based sequencing methods.
Methods Mol Biol. 825:223–235. 2012. View Article : Google Scholar
|
|
27
|
Becker D, Lutsik P, Ebert P, Bock C,
Lengauer T and Walter J: BiQ Analyzer HiMod: An interactive
software tool for high-throughput locus-specific analysis of
5-methylcytosine and its oxidized derivatives. Nucleic Acids Res.
42(W1): W501–W507. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Arranz-Valsero I, Soriano-Romaní L,
García-Posadas L, López-García A and Diebold Y: IL-6 as a corneal
wound healing mediator in an in vitro scratch assay. Exp Eye Res.
125:183–192. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Guo J, Lin P, Zhao X, Zhang J, Wei X, Wang
Q and Wang C: Etazolate abrogates the lipopolysaccharide
(LPS)-induced downregulation of the cAMP/pCREB/BDNF signaling,
neuro-inflammatory response and depressive-like behavior in mice.
Neuroscience. 263:1–14. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang DK, Choi BY, Lee YH, Kim YG, Cho MC,
Hong SE, Kim H, Hajjar RJ and Park WJ: Gene profiling during
regression of pressure overload-induced cardiac hypertrophy.
Physiol Genomics. 30:1–7. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lee SH, Yang DK, Choi BY, Lee YH, Kim SY,
Jeong D, Hajjar RJ and Park WJ: The transcription factor Eya2
prevents pressure overload-induced adverse cardiac remodeling. J
Mol Cell Cardiol. 46:596–605. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lee SH, Kim J, Ryu JY, Lee S, Yang DK,
Jeong D, Kim J, Lee SH, Kim JM, Hajjar RJ, et al: Transcription
coactivator Eya2 is a critical regulator of physiological
hypertrophy. J Mol Cell Cardiol. 52:718–726. 2012. View Article : Google Scholar
|
|
33
|
Patrick AN, Cabrera JH, Smith AL, Chen XS,
Ford HL and Zhao R: Structure-function analyses of the human
SIX1-EYA2 complex reveal insights into metastasis and BOR syndrome.
Nat Struct Mol Biol. 20:447–453. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ohto H, Kamada S, Tago K, Tominaga SI,
Ozaki H, Sato S and Kawakami K: Cooperation of six and eya in
activation of their target genes through nuclear translocation of
Eya. Mol Cell Biol. 19:6815–6824. 1999.PubMed/NCBI
|
|
35
|
Grifone R, Demignon J, Giordani J, Niro C,
Souil E, Bertin F, Laclef C, Xu PX and Maire P: Eya1 and Eya2
proteins are required for hypaxial somitic myogenesis in the mouse
embryo. Dev Biol. 302:602–616. 2007. View Article : Google Scholar
|
|
36
|
Embry AC, Glick JL, Linder ME and Casey
PJ: Reciprocal signaling between the transcriptional co-factor Eya2
and specific members of the Galphai family. Mol Pharmacol.
66:1325–1331. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ali-Khan SE and Hales BF: Novel retinoid
targets in the mouse limb during organogenesis. Toxicol Sci.
94:139–152. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Molinari M: Cell cycle checkpoints and
their inactivation in human cancer. Cell Prolif. 33:261–274. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Fu J, Xu X, Kang L, Zhou L, Wang S, Lu J,
Cheng L, Fan Z, Yuan B, Tian P, et al: miR-30a suppresses breast
cancer cell proliferation and migration by targeting Eya2. Biochem
Biophys Res Commun. 445:314–319. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Clark SW, Fee BE and Cleveland JL:
Misexpression of the eyes absent family triggers the apoptotic
program. J Biol Chem. 277:3560–3567. 2002. View Article : Google Scholar
|
|
41
|
Matt N, Dupé V, Garnier JM, Dennefeld C,
Chambon P, Mark M and Ghyselinck NB: Retinoic acid-dependent eye
morphogenesis is orchestrated by neural crest cells. Development.
132:4789–4800. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li X, Oghi KA, Zhang J, Krones A, Bush KT,
Glass CK, Nigam SK, Aggarwal AK, Maas R, Rose DW, et al: Eya
protein phosphatase activity regulates Six1-Dach-Eya
transcriptional effects in mammalian organogenesis. Nature.
426:247–254. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kohrt D, Crary J, Zimmer M, Patrick AN,
Ford HL, Hinds PW and Grossel MJ: CDK6 binds and promotes the
degradation of the EYA2 protein. Cell Cycle. 13:62–71. 2014.
View Article : Google Scholar :
|
|
44
|
Bonini NM, Leiserson WM and Benzer S: The
eyes absent gene: Genetic control of cell survival and
differentiation in the developing Drosophila eye. Cell. 72:379–395.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Pandey RN, Rani R, Yeo EJ, Spencer M, Hu
S, Lang RA and Hegde RS: The Eyes Absent phosphatase-transactivator
proteins promote proliferation, transformation, migration, and
invasion of tumor cells. Oncogene. 29:3715–3722. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Krueger AB, Drasin DJ, Lea WA, Patrick AN,
Patnaik S, Backos DS, Matheson CJ, Hu X, Barnaeva E, Holliday MJ,
et al: Allosteric inhibitors of the Eya2 phosphatase are selective
and inhibit Eya2-mediated cell migration. J Biol Chem.
289:16349–16361. 2014. View Article : Google Scholar : PubMed/NCBI
|
